Ticker brief
NRIX NURIX THERAPEUTICS INC
Consumer, Non-cyclical · Biotechnology
last close
$26.14
1 day
+3.2%
14 days
-2.2%
mkt cap
$2.5B
signals 14d
11
authors 14d
10
crowd 14d
+1.8σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 90% | IV/HV 1.96× (as of 2023-06-06) |
| Skew — 25Δ RR 30d | +0.007 | 25Δ call IV − put IV |
| OI alarm | quiet | last alarm 2026-06-09 (z=5.1) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-07 → 2026-10-14 · now +0.30 (−1 bearish … +1 bullish)
Who spoke10
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OptionsFlowBoss | C | · | 2 | +0.00 |
| @CrweWorld | C | · | 1 | +0.20 |
| @OzmosiHealth | C | · | 1 | +0.20 |
| @financespotnews | C | +0.40 | 1 | +0.10 |
| @cnfinancewatch | B | -1.23 | 1 | +0.60 |
| @faststocknewss | C | +1.70 | 1 | +0.60 |
| @GetPursa | C | +0.10 | 1 | +0.45 |
| @FwdQuarter | C | · | 1 | +0.45 |
| @d__risk | B | · | 1 | -0.35 |
| @TWFeditor | C | -1.36 | 1 | +0.60 |
Recent signals11of 11 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @TWFeditor | +0.60 | Reports NRIX resuming its climb after volatility. | — | tweet ↗ |
| 2026-10-14 | @OptionsFlowBoss | +0.00 | Reports open-interest changes with direction visible only in the chart. | — | tweet ↗ |
| 2026-10-13 | @d__risk | -0.35 | Peer-heavy risk disclosure offsets cash and profitability with clinical and scale-up risks. | — | tweet ↗ |
| 2026-10-13 | @OptionsFlowBoss | +0.00 | Flags unusual options activity but gives no textual direction. | — | tweet ↗ |
| 2026-10-13 | @FwdQuarter | +0.45 | Reports cash runway and multiple clinical-program advances for Nurix. | — | tweet ↗ |
| 2026-10-12 | @GetPursa | +0.45 | Nurix reports $673.1M revenue and $549.8M profit, largely from a Roche payment. | — | tweet ↗ |
| 2026-10-12 | @faststocknewss | +0.60 | Reports Nurix Q3 net income of $549.8M, EPS of $4.73 and detailed profitability figures. | — | tweet ↗ |
| 2026-10-12 | @cnfinancewatch | +0.60 | Classifies US stock candidates into breakout, pullback and bottom-reversal structures. | — | tweet ↗ |
| 2026-10-08 | @financespotnews | +0.10 | Nurix is scheduled to report earnings Thursday after the close. | — | tweet ↗ |
| 2026-10-07 | @OzmosiHealth | +0.20 | Reports first-patient enrollment in a Phase 1b/2 bexobrutideg combination study. | — | tweet ↗ |
| 2026-10-07 | @CrweWorld | +0.20 | Reports enrollment of the first patient in a Phase 1b/2 combination study. | — | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.